Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulations of terameprocol and temozolomide and their use in stimulation of humoral immunity in tumors

Formulations of terameprocol and temozolomide and their use in stimulation of humoral immunity in tumors

US Patent 12171729 · Granted Dec 24, 2024

Estimated economic value: $126,871,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bidens pilosa and its phytochemicals for use in prevention and treatment of diar2025
Light-emitting device2025
Transparent electronic device and manufacturing method thereof2025
Artificial intelligent system for managing a poultry house2025
Light-emitting device2025
High heel shoe2025
Light-emitting device2024
Semiconductor light-emitting device2024
Light emitting device and manufacturing method thereof2024
Method of forming semiconductor package transmission lines with micro-bump lines2024
Multi-shot moulding part structure2024
Light-emitting device2024